Uncovering early markers of Parkinson's disease pathological progression using proteomics

被引:0
|
作者
Pressey, S. N.
Murray, C. E.
Heywood, W.
Gentleman, S. M.
Mills, K.
Holton, J. L.
Gandhi, S.
Revesz, T.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1035
引用
收藏
页码:S369 / S369
页数:1
相关论文
共 50 条
  • [21] Modeling Parkinson's disease progression accounting for the effect of symptomatic treatments in the Parkinson's Progression Markers Initiative study
    Ribba, B.
    Simuni, T.
    Marek, K.
    Siderowf, A.
    Chahine, L.
    Diack, C.
    Monnet, A.
    Ricci, B.
    Nikolcheva, T.
    Pagano, G.
    MOVEMENT DISORDERS, 2023, 38 : S568 - S569
  • [22] The Role of Vitamin D in Disease Progression in Early Parkinson's Disease
    Sleeman, Isobel
    Aspray, Terry
    Lawson, Rachael
    Coleman, Shirley
    Duncan, Gordon
    Khoo, Tien K.
    Schoenmakers, Inez
    Rochester, Lynn
    Burn, David
    Yarnall, Alison
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (04) : 669 - 675
  • [23] The progression markers in the premotor phase (PMPP) of Parkinson's disease study
    Liepelt-Scarfone, I.
    Mueller, K.
    Bormann, C.
    Gauss, K.
    Streffer, J.
    Berg, D.
    MOVEMENT DISORDERS, 2012, 27 : S3 - S3
  • [24] Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change
    Ren, Xuehan
    Lin, Jeffrey
    Stebbins, Glenn T.
    Goetz, Christopher G.
    Luo, Sheng
    MOVEMENT DISORDERS, 2021, 36 (12) : 2853 - 2861
  • [25] Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change
    Ren, X.
    Lin, J.
    Stebbins, G.
    Goetz, C.
    Luo, S.
    MOVEMENT DISORDERS, 2021, 36 : S298 - S299
  • [26] Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation
    Zhang, Qiu-Shuang
    Heng, Yang
    Yuan, Yu-He
    Chen, Nai-Hong
    TOXICOLOGY LETTERS, 2017, 265 : 30 - 37
  • [27] Associations between Early Markers of Parkinson's Disease and Sarcopenia
    Drey, Michael
    Hasmann, Sandra E.
    Krenovsky, Jan-Peter
    Hobert, Markus A.
    Straub, Stefanie
    Elshehabi, Morad
    von Thaler, Anna-Katharina
    Fallgatter, Andreas J.
    Eschweiler, Gerhard W.
    Suenkel, Ulrike
    Berg, Daniela
    Maetzler, Walter
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [28] Early biomechanical markers of postural instability in Parkinson's disease
    McVey, Molly A.
    Stylianou, Antonis P.
    Luchies, Carl W.
    Lyons, Kelly E.
    Pahwa, Rajesh
    Jernigan, Stephen
    Mahnken, Jonathan D.
    GAIT & POSTURE, 2009, 30 (04) : 538 - 542
  • [29] Effect of lazabemide on the progression of disability in early Parkinson's disease
    Kieburtz, K
    McDermott, M
    Shoulson, I
    Fahn, S
    Brin, M
    Goetz, C
    Lang, A
    Olanow, CW
    LeWitt, P
    Mistura, K
    Waters, C
    Welsh, M
    Rodnitzky, R
    Dobson, J
    Argatoff, P
    Tanner, C
    Lewis, P
    Watts, R
    Bryan, B
    Comella, C
    Jaglin, JA
    Shults, C
    Fontaine, D
    Bressman, SB
    Moskowitz, C
    Hurtig, HI
    Shallow, K
    Hubble, J
    Barter, R
    Bennett, JP
    RostRuffner, E
    Perlmutter, JS
    McGeeMinnich, L
    Hauser, R
    Gauger, L
    Rajput, AH
    Sutton, A
    Trinidad, K
    Gardiner, IF
    Singer, C
    Sheldon, C
    Fink, JS
    Tennis, M
    Baker, D
    Bourgeois, K
    Casaceli, C
    Claude, K
    Hickey, G
    Nobel, R
    Oakes, D
    ANNALS OF NEUROLOGY, 1996, 40 (01) : 99 - 107
  • [30] Peripheral blood inflammatory markers in early Parkinson's disease
    Kim, Ryul
    Kim, Han-Joon
    Kim, Aryun
    Jang, Mihee
    Kim, Ahro
    Kim, Yoon
    Yoo, Dallah
    Im, Jin Hee
    Choi, Ji-Hyun
    Jeon, Beomseok
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 58 : 30 - 33